Dehydroequol

CAS: 81267-65-4

Ref. 3D-XD161694

Produktinformation

• Name: Dehydroequol
• Synonyme: 7,4?-Dihydroxyisoflav-3-ene3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-olHaginin E, 2H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)-, 3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol, 3-(4-Hydroxyphenyl)-2H-benzopyran-7-ol, 3-(4-hydroxyphenyl)-2H-chromen-7-ol, D 7446, Haginin E, Idronoxil, Nv 06
• CAS: 81267-65-4

Beschreibung

Dehydroequol is a prebiotic that is used to treat inflammatory bowel disease. It has been shown to have an effect on the body's metabolism, with possible synergic effects when combined with other therapies such as antibiotics. Dehydroequol is a natural metabolite of the soy isoflavone daidzein and has been shown to inhibit cyclase activity in prostate cancer cells. A recent study found that equol had an anti-inflammatory effect in human feces and may be useful for treating skin cancer. Researchers are continuing to explore the use of dehydroequol in other areas such as bovine mastitis and high-resistant bacterial strains.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 240.25 g/mol
• Formel: C₁₅H₁₂O₃
• Reinheit: Min. 95%